Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents

References

• Arayne MS, Sultana N, Bibi Z. (2005). Grape fruit juice–drug interactions. Pak J Pharm Sci 18:45–57
   PubMedGoogle Scholar
• Baati T, Horcajada P, Gref R, et al. (2012). In vitro determination of the CYP 3A4 activity in rat hepatic microsomes by liquid-phase extraction and HPLC-photodiode array detection. J Pharmacol Toxicol Methods 66:29–34
   PubMed Web of Science ®Google Scholar
• Baliga MS, Bhat HP, Pereira MM, et al. (2010). Radioprotective effects of Aegle marmelos (L.) Correa (Bael): a concise review. J Altern Complement Med 16:1109–16
   PubMed Web of Science ®Google Scholar
• Crespi CL, Miller VP, Penman BW. (1997). Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal Biochem 248:188–90
   PubMed Web of Science ®Google Scholar
• Fujita T, Kawase A, Niwa T, et al. (2008). Comparative evaluation of 12 immature citrus fruit extracts for the inhibition of cytochrome P450 isoform activities. Biol Pharm Bull 31:925–30
   PubMed Web of Science ®Google Scholar
• Gautam MK, Ghatule RR, Singh A, et al. (2013). Healing effects of Aegle marmelos (L.) Correa fruit extract on experimental colitis. Indian J Exp Biol 51:157–64
   PubMed Web of Science ®Google Scholar
• Guo LQ, Yamazoe Y. (2004). Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharmacol Sin 25:129–36
   PubMed Web of Science ®Google Scholar
• Kamalakkannan N, Prince PS. (2003). Hypoglycaemic effect of water extracts of Aegle marmelos fruits in streptozotocin diabetic rats. J Ethnopharmacol 87:207–10
   PubMed Web of Science ®Google Scholar
• Lewis DF, Modi S, Dickins M. (2001). Quantitative structure-activity relationships (QSARs) within substrates of human cytochromes P450 involved in drug metabolism. Drug Metabol Drug Interact 18:221–42
   PubMedGoogle Scholar
• Li X, He Y, Ruiz CH, et al. (2009). Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways. Drug Metab Dispos 37:1242–50
   PubMed Web of Science ®Google Scholar
• Lynch T, Price A. (2007). The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician 76:391–6
   PubMed Web of Science ®Google Scholar
• Maity P, Hansda D, Bandyopadhyay U, Mishra DK. (2009). Biological activities of crude extracts and chemical constituents of Bael, Aegle marmelos (L.) Corr. Indian J Exp Biol 47:849–61
   PubMed Web of Science ®Google Scholar
• Manda VK, Avula B, Ali Z, et al. (2014a). Evaluation of in vitro absorption, distribution, metabolism, and excretion (ADME) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline. Planta Med 80:568–76
   PubMed Web of Science ®Google Scholar
• Manda VK, Avula B, Ali Z, et al. (2013). Characterization of in vitro ADME properties of diosgenin and dioscin from Dioscorea villosa. Planta Med 79:1421–8
   PubMed Web of Science ®Google Scholar
• Manda VK, Dale OR, Awortwe C, et al. (2014b). Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents. Front Pharmacol 5:178
   PubMed Web of Science ®Google Scholar
• Obach RS, Walsky RL, Venkatakrishnan K. (2007). Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions. Drug Metab Dispos 35:246–55
   PubMed Web of Science ®Google Scholar
• Orr ST, Ripp SL, Ballard TE, et al. (2012). Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug–drug interaction risks. J Med Chem 55:4896–933
   PubMed Web of Science ®Google Scholar
• Owens C, Baergen R, Puckett D. (2014). Online sources of herbal product information. Am J Med 127:109–15
   PubMed Web of Science ®Google Scholar
• Paine MF, Widmer WW, Hart HL, et al. (2006). A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction. Am J Clin Nutr 83:1097–105
   PubMed Web of Science ®Google Scholar
• Roytman MM, Porzgen P, Lee CL, et al. (2014). Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am J Gastroenterol 109:1296–8
   PubMed Web of Science ®Google Scholar
• Sadyandy R, Fernandes R, Kumar P. (2005). An asymmetric dihydroxylation route to (R)-(-)-octopamine, (R)-(-)-tembamide and (R)-(-)-aegeline. ARKIVOC (Gainesville, FL, United States) 3:36–43
   Google Scholar
• Shinde PB, Laddha KS. (2014). Simultaneous quantification of furanocoumarins from Aegle marmelos fruit pulp extract. J Chromatogr Sci 53:576–9
   PubMed Web of Science ®Google Scholar
• Teng WC, Oh JW, New LS, et al. (2010). Mechanism-based inactivation of cytochrome P450 3A4 by lapatinib. Mol Pharmacol 78:693–703
   PubMed Web of Science ®Google Scholar
• Ueng YF, Chen CC, Chung YT, et al. (2011). Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo. Br J Pharmacol 163:1250–62
   PubMed Web of Science ®Google Scholar
• Wang RW, Newton DJ, Scheri TD, Lu AY. (1997). Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis. Drug Metab Dispos 25:502–7
   PubMed Web of Science ®Google Scholar
• Wang X, Lee WY, Or PM, Yeung JH. (2009). Effects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates. Phytomedicine 16:712–25
   PubMed Web of Science ®Google Scholar
• Zhou S, Yung Chan S, Cher Goh B, et al. (2005). Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet 44:279–304
   PubMed Web of Science ®Google Scholar